Mongolia issues a new action plan for noncommunicable diseases
Mongolia, with the support of the World Health Organization (WHO), launched its National Action Plan for noncommunicable diseases (NCDs) 2026–2028 to tackle diseases that cause 81% ...
Mongolia inaugurates the new National Reference Laboratory for Medicines and Medical Devices
The Government of Mongolia inaugurated a new National Reference Laboratory for Medicines and Medical Devices, strengthening the country’s capacity to manage public health emergenci ...
WHO advances partnership for science and research in Mongolia
The World Health Organization (WHO) convened a roundtable meeting to launch the Mongolia Partnership for Science and Research for Health, bringing together diverse stakeholders to ...
The Government of Japan extends funding support to WHO Mongolia to strengthen local health systems for disease outbreak preparedness and response
The Government of Japan has provided US$ 400 000 to support WHO Mongolia in strengthening local health system capacity for infectious disease outbreak response. The funding will en ...
Sustaining gains in vaccine-preventable diseases: WHO supports review of Mongolia’s national immunization programme
WHO supports Mongolia’s response to bacterial meningitis and meningococcal disease
MOH and WHO concludes pilot on HPV testing for cervical cancer screening in Mongolia
Safeguarding Mongolia’s polio-free future: WHO initiates review of acute flaccid paralysis surveillance in a changing global risk environment
Alcohol marketing: Evidence, emerging challenges and policy responses – with lessons from tobacco and breastmilk substitute marketing restrictions
Clinical Diagnostic Stewardship – An integral component of the national AMR response
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib)
WHO issues first ever guidance to advance child-focused dengue treatments
Caring for non-communicable diseases during pregnancy, expert convening
Open letter to leaders of G7, G20, BRICS and all nations on finalizing the WHO Pandemic Agreement’s Pathogen Access and Benefit Sharing annex
